JP2024508498A5 - - Google Patents
Info
- Publication number
- JP2024508498A5 JP2024508498A5 JP2023552525A JP2023552525A JP2024508498A5 JP 2024508498 A5 JP2024508498 A5 JP 2024508498A5 JP 2023552525 A JP2023552525 A JP 2023552525A JP 2023552525 A JP2023552525 A JP 2023552525A JP 2024508498 A5 JP2024508498 A5 JP 2024508498A5
- Authority
- JP
- Japan
- Prior art keywords
- reboxetine
- acceptable salt
- oxybutynin
- pharmacologically acceptable
- mra
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163156463P | 2021-03-04 | 2021-03-04 | |
| US63/156,463 | 2021-03-04 | ||
| PCT/US2022/018604 WO2022187420A1 (en) | 2021-03-04 | 2022-03-03 | Combination of reboxetine and a muscarinic receptor antagonist (mra) for use in treating sleep apnea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508498A JP2024508498A (ja) | 2024-02-27 |
| JP2024508498A5 true JP2024508498A5 (https=) | 2025-03-10 |
Family
ID=80999274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023552525A Pending JP2024508498A (ja) | 2021-03-04 | 2022-03-03 | 睡眠時無呼吸の治療における使用のためのレボキセチン及びムスカリン受容体拮抗薬（ｍｒａ）の組み合わせ |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240139200A1 (https=) |
| EP (1) | EP4301353A1 (https=) |
| JP (1) | JP2024508498A (https=) |
| KR (1) | KR20230154186A (https=) |
| CN (1) | CN116916909A (https=) |
| AU (1) | AU2022231133A1 (https=) |
| CA (1) | CA3210092A1 (https=) |
| WO (1) | WO2022187420A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| CA2431041A1 (en) * | 2001-01-02 | 2002-07-11 | Pharmacia & Upjohn Company | New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
| US20070196481A1 (en) * | 2002-07-25 | 2007-08-23 | Amidon Gregory E | Sustained-release tablet composition |
| GEAP202416602A (en) * | 2017-04-28 | 2024-10-10 | Brigham & Womens Hospital Inc | Methods and compositions for treating sleep apnea |
| KR102874891B1 (ko) * | 2018-01-30 | 2025-10-21 | 애프니메드, 인코포레이티드 (델라웨어) | 수면 무호흡증을 치료하기 위한 방법 및 조성물 |
-
2022
- 2022-03-03 AU AU2022231133A patent/AU2022231133A1/en not_active Abandoned
- 2022-03-03 US US18/548,604 patent/US20240139200A1/en active Pending
- 2022-03-03 KR KR1020237029510A patent/KR20230154186A/ko active Pending
- 2022-03-03 CA CA3210092A patent/CA3210092A1/en active Pending
- 2022-03-03 JP JP2023552525A patent/JP2024508498A/ja active Pending
- 2022-03-03 CN CN202280018649.9A patent/CN116916909A/zh active Pending
- 2022-03-03 EP EP22714033.2A patent/EP4301353A1/en not_active Withdrawn
- 2022-03-03 WO PCT/US2022/018604 patent/WO2022187420A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023139000A5 (https=) | ||
| JP7488201B2 (ja) | デクスメデトミジンを含むフィルム製剤、及びその作製方法 | |
| CN103596551B (zh) | 含有用于掩味的离子交换树脂的食用口服条或糯米纸囊剂型 | |
| US20110280925A1 (en) | Dual And Single Layer Dosage Forms | |
| CN110799181A (zh) | 用于治疗睡眠呼吸暂停的方法和组合物 | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| TW200932207A (en) | Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas | |
| AU2010343147A1 (en) | Orally administrable film dosage forms containing ondansetron | |
| JP5362151B2 (ja) | Ｐｇｄ２拮抗剤及びヒスタミン拮抗剤からなるアレルギー性鼻炎治療用医薬 | |
| TWI820673B (zh) | 布瑞哌唑口溶膜組合物、其製備方法及用途 | |
| AU2008259864C1 (en) | Methods and compositions for administration of Oxybutynin | |
| Landová et al. | Oral mucosa and therapy of recurrent aphthous stomatitis | |
| JP2024508498A5 (https=) | ||
| TWI820674B (zh) | 布瑞哌唑物口腔薄膜劑、其製備方法及用途 | |
| TW200534852A (en) | 4-methylpyrazole formulations for inhibiting ethanol intolerance | |
| JP2024523876A5 (https=) | ||
| JP2024511091A5 (https=) | ||
| AU2010345621B2 (en) | Use of pentoxifylline for preventing or treating constipation | |
| WO2008052431A1 (en) | Use of composition comprising amlodipine in preparing medicaments for treating a lower urinary tract disorder | |
| JP2024534173A5 (https=) | ||
| CN108261411A (zh) | 用于婴幼儿血管瘤治疗的口腔膜剂及其制备方法 | |
| CN101849926A (zh) | 酒石酸唑吡坦膜剂 | |
| TW200533361A (en) | Medicinal composition for treating allergic symptoms | |
| JP5463019B2 (ja) | エピナスチン類とエフェドリン類とを含有する気道杯細胞過形成を抑制するための医薬組成物 | |
| CN120617220A (zh) | 一种地氯雷他定口溶膜组合物、其制备方法及应用 |